STOCK TITAN

Envista Holdings Corporation - NVST STOCK NEWS

Welcome to our dedicated page for Envista Holdings Corporation news (Ticker: NVST), a resource for investors and traders seeking the latest updates and insights on Envista Holdings Corporation stock.

Envista Holdings Corporation (NYSE: NVST) is a leading global dental products company committed to empowering dental professionals worldwide. Headquartered in Brea, California, Envista develops, manufactures, and markets an extensive portfolio of dental consumables, equipment, and services. The company operates through two primary segments: Specialty Products & Technologies and Equipment & Consumables.

The Specialty Products & Technologies segment focuses on dental implant systems, regenerative solutions, dental prosthetics, orthodontic systems, and lab products. This segment is dedicated to advancing the capabilities of dental professionals through innovative products and technologies.

The Equipment & Consumables segment offers a broad range of dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization and magnification systems, supporting the diagnostic, treatment, and prevention needs of dental conditions.

Envista has a strong commitment to continuous improvement, action-oriented innovation, and a deep respect for dental professionals. Its comprehensive product portfolio covers an estimated 90% of dentists’ clinical needs, ensuring a holistic approach to dental care.

Recent achievements include the launch of the DEXIS digital ecosystem, an AI-powered platform designed to streamline implant dentistry workflows. This interconnected system combines cutting-edge CBCT, intraoral scanning, diagnostics, and treatment planning, empowering clinicians to manage implant cases efficiently.

Envista continues to innovate with products like the ORTHOPANTOMOGRAPH™ OP 3D™ LX, which enhances 3D diagnostic capabilities, and the IS ScanFlow software, which integrates AI-driven tools to maximize productivity in dental practices.

Financially, Envista reported sales of $623.6 million for the first quarter of 2024, with core sales growth and ongoing investments aimed at accelerating growth and profitability. The company has a proven track record of resilience and strategic differentiation, particularly through the challenges posed by the global pandemic and other economic factors.

Envista's philanthropic arm, the Envista Smile Project, exemplifies its commitment to social responsibility. The project has donated millions to improve access to oral health for underserved communities, partnering with institutions like the University of Southern California to enhance dental care for vulnerable populations.

Envista's significant market positions in attractive dental segments, coupled with its continuous improvement culture and innovation-driven approach, make it a pivotal player in the dental industry. For more information, visit the official website at www.envistaco.com.

Rhea-AI Summary
DEXIS introduces IS ScanFlow v.1.0.10, enhancing dental implant workflows with guided workflows and AI capabilities. The update aims to boost productivity for clinicians by simplifying data capture in complex situations, automating manual tasks, and facilitating efficient lab communication. Early adopters have provided positive feedback on the system's ease of use and accuracy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.49%
Tags
none
-
Rhea-AI Summary
Envista Holdings Corporation (NVST) has initiated the process to select a new CEO to succeed Amir Aghdaei, who will continue as President until the appointment. The board is actively searching for external candidates to drive the company's future growth and transformation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.19%
Tags
none
-
Rhea-AI Summary
DEXIS introduces an AI-powered digital ecosystem for implant dentistry workflows, offering integrated tools for diagnosis, treatment planning, and collaboration. The platform includes advanced imaging technology, AI-driven software, and user-friendly features to enhance clinical efficiency and patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.92%
Tags
AI
Rhea-AI Summary
Envista Holdings Corporation (NVST) reported a decline in core sales by 2.0% in Q4 2023, with a net loss of $217.4 million. Adjusted net income was $49.7 million, down from $91.9 million in Q4 2022. The company is focusing on improving Spark profitability and accelerating its North American implant business in 2024, expecting low-single digit core sales growth and adjusted EBITDA margins of 16% - 17%. The company delivered $223.6 million of free cash flow for the full year 2023, representing an increase of more than $100 million over 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.43%
Tags
-
Rhea-AI Summary
Envista Holdings Corporation (NVST) has joined Women in DSO as a Platinum Industry partner, demonstrating its commitment to advancing female leadership in dentistry. The partnership aims to support women in realizing their career aspirations and developing the next generation of female leaders in the dental space.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.02%
Tags
partnership
-
Rhea-AI Summary
Envista Holdings Corporation (NVST) announced an Investor Event at the Envista Summit on February 16, 2024. The event will feature a management presentation and interactive Q&A. The Summit aims to provide dental professionals with training and education on the company's product portfolio and digitally integrated solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.08%
Tags
conferences
Rhea-AI Summary
Envista Holdings Corporation (NVST) will report financial results for its fourth quarter 2023 on Wednesday, February 7, 2024. The earnings press release, webcast slides, and related presentation materials will be available on the company's website. A conference call to discuss the results will take place at 2:00 PM PT on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.06%
Tags
-
Rhea-AI Summary
Envista Holdings Corporation (NYSE: NVST) to participate in J.P. Morgan Healthcare Conference on January 8, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.1%
Tags
none
-
Rhea-AI Summary
Envista Holdings Corporation (NYSE: NVST) has announced the appointment of Robert Befidi as President, Diagnostics; Suraj Satpathy as Chief Human Resources Officer; and Andrew Chen as Chief Information Officer. The company also revealed the departure of Patrik Eriksson, Nobel Biocare's current president, and the ongoing search for a permanent Chief Financial Officer. These strategic moves aim to enhance leadership capabilities, accelerate growth, and drive digital transformation in oral care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.24%
Tags
management
Rhea-AI Summary
Envista Holdings Corporation (NYSE: NVST) announced its 2022 Sustainability Report, emphasizing its commitment to ESG considerations in digitizing, personalizing, and democratizing dental care. The report highlights a 20% reduction in greenhouse gas emissions, $650,000 investment in oral health-focused non-profits, and the establishment of a Sustainability Council. Envista achieved 99% gender and ethnic pay equity in the U.S. and improved employee health and safety outcomes. CEO Amir Aghdaei expressed pride in the company's progress and emphasized the importance of sustainability for long-term success.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.65%
Tags
none

FAQ

What is the current stock price of Envista Holdings Corporation (NVST)?

The current stock price of Envista Holdings Corporation (NVST) is $17.44 as of September 6, 2024.

What is the market cap of Envista Holdings Corporation (NVST)?

The market cap of Envista Holdings Corporation (NVST) is approximately 3.0B.

What does Envista Holdings Corporation do?

Envista Holdings Corporation develops, manufactures, and markets dental consumables, equipment, and services to dental professionals worldwide.

What are the main segments of Envista's business?

Envista operates through two primary segments: Specialty Products & Technologies, and Equipment & Consumables.

What recent achievements has Envista made?

Recently, Envista launched the DEXIS digital ecosystem, an AI-powered platform for implant dentistry, and the ORTHOPANTOMOGRAPH™ OP 3D™ LX for enhanced 3D diagnostics.

How did Envista perform financially in the first quarter of 2024?

Envista reported sales of $623.6 million, with a net income of $23.6 million or $0.14 per diluted share for the first quarter of 2024.

What is the Envista Smile Project?

The Envista Smile Project is a philanthropic foundation aimed at improving oral health for disadvantaged communities through donations and medical mission trips.

Who is the new CEO of Envista Holdings Corporation?

Paul Keel was appointed as the new CEO of Envista Holdings Corporation effective May 1, 2024.

How does Envista support dental professionals?

Envista supports dental professionals by providing a comprehensive portfolio of dental consumables, solutions, technology, and services.

What is the DEXIS digital ecosystem?

The DEXIS digital ecosystem is an interconnected, AI-powered platform designed to streamline and manage the implant dentistry workflow.

What is the Envista Business System (EBS)?

The Envista Business System (EBS) is a methodology that underpins the company's operations, focusing on continuous improvement and innovation.

Where can I find more information about Envista Holdings Corporation?

For more information, please visit Envista's official website at www.envistaco.com.

Envista Holdings Corporation

NYSE:NVST

NVST Rankings

NVST Stock Data

3.02B
171.95M
0.74%
112.16%
6.5%
Medical Instruments & Supplies
Dental Equipment & Supplies
Link
United States of America
BREA